Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania B Porras

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncotarget|February 23, 2018
Challenges in using liquid biopsies for gene expression profilingTania B Porras, Pushpinder Kaur, Alexander Ring, et al.
Scientific Reports|February 8, 2019
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancerPushpinder Kaur, Tania B Porras, Alexander Ring, et al.
British Journal of Cancer|August 29, 2021
Identification of putative actionable alterations in clinically relevant genes in breast cancerPushpinder Kaur, Tania B Porras, Anthony Colombo, et al.
Cancers|February 10, 2024
Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer SubtypesPushpinder Kaur, Alexander Ring, Tania B Porras, et al.
International Journal of Molecular Sciences|July 12, 2020
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast CancerPushpinder Kaur, Daniel Campo, Tania B Porras, et al.
The Prostate|November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytesLisa Yan, Diane M Da Silva, Bhavna Verma, et al.
The Journal of General Virology|November 12, 2015
Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infectionJoseph G Skeate, Tania B Porras, Andrew W Woodham, et al.
Annals of Surgical Oncology|January 9, 2022
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncotarget|February 23, 2018
Challenges in using liquid biopsies for gene expression profilingTania B Porras, Pushpinder Kaur, Alexander Ring, et al.
Scientific Reports|February 8, 2019
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancerPushpinder Kaur, Tania B Porras, Alexander Ring, et al.
British Journal of Cancer|August 29, 2021
Identification of putative actionable alterations in clinically relevant genes in breast cancerPushpinder Kaur, Tania B Porras, Anthony Colombo, et al.
Cancers|February 10, 2024
Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer SubtypesPushpinder Kaur, Alexander Ring, Tania B Porras, et al.
International Journal of Molecular Sciences|July 12, 2020
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast CancerPushpinder Kaur, Daniel Campo, Tania B Porras, et al.
The Prostate|November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytesLisa Yan, Diane M Da Silva, Bhavna Verma, et al.
The Journal of General Virology|November 12, 2015
Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infectionJoseph G Skeate, Tania B Porras, Andrew W Woodham, et al.
Annals of Surgical Oncology|January 9, 2022
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
Pageof 1